Searched for
NAFITHROMYCIN
FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...- India develops first indigenously discovered antibiotic "Nafithromycin" effective against resistant respiratory infectionsIndia has proudly introduced Nafithromycin, its first homegrown antibiotic, tackling stubborn respiratory infections with groundbreaking ef...
- India emerges as a global leader across key sectors in 2024In 2024, India demonstrated its global leadership with advancements in pharmaceuticals, biotechnology, defence, nuclear energy, and space. ...
- Wockhardt chairman seeks GST exemption for antibiotics discovered in IndiaWockhardt founder sought GST exemption for antibiotics discovered in India. He said this will make the drugs more affordable. The statement...
- Wockhardt gets favourable recommendation from CDSCO for antibiotic for CABPWockhardt's new antibiotic, Miqnaf, has received a favourable recommendation from the Central Drugs Standard Control Organisation for treat...
- Habil Khorakiwala on 3 things in the pipeline that can cause a re-rating for WockhardtHabil Khorakiwala says: “We have earlier signed an agreement on a profit-sharing basis for contract manufacturing with Serum Institute to m...
- Adani Group, HAL, Linde among top gainers of the weekInfra stocks were buzzing after the government announced a huge Rs 6 lakh crore National Monetisation Pipeline to unlock value in brownfiel...
- Biggest gainers & losers of the day: Sudarshan Chemical soars 20%; Arvind Fashion declinesAmong stock-specific action, speciality chemical players and infrastructure themes remained in demand. On the other hand, investors continu...
- Biggest gainers & losers of the day: ESAB India rallies 16%; Linde India tanksESAB India and Swan Energy gained on the positive news flow, whereas investors booked profits in the recent gainers. Cash strapped Vodafone...
- Wockhardt, Jemincare partner for novel respiratory antibiotic NafithromycinOn the development, Wockhardt Group Founder Chairman Habil Khorakiwala said Wockhardt has been at the forefront in the fight against Anti-M...
Load More
